2021
DOI: 10.1016/j.tibs.2020.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial Dysfunction and Mitophagy in Parkinson’s Disease: From Mechanism to Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
236
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 301 publications
(241 citation statements)
references
References 109 publications
2
236
0
3
Order By: Relevance
“…To our knowledge, the most studied and understood mitophagy pathway is mediated by PTEN-induced kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin (Narendra et al, 2008;Vives-Bauza et al, 2010), both of which have been linked to forms of Parkinson's disease (Kitada et al, 1998;Valente et al, 2004). The complicated mechanisms of canonical and non-canonical PINK1/parkinmediated mitophagy have been well summarized in previous reviews (Eiyama and Okamoto, 2015;Lazarou et al, 2015;Nguyen et al, 2016;Clark et al, 2020;Malpartida et al, 2020). Moreover, two main types of receptor-mediated mitophagy pathway have been classified as follows in brief: ubiquitinindependent mitophagy receptors, including BCL2-interacting protein 3 (BNIP3) (Quinsay et al, 2010), BCL2-interacting protein 3 like (NIX/BNIP3L) (Sandoval et al, 2008), FUN14 domain-containing 1 (FUNDC1) (Liu et al, 2012), BCL2-like 13 (BCL2L13) (Otsu et al, 2015), autophagy and beclin 1 regulator 1 (AMBRA1) (Strappazzon et al, 2015), FKBP prolyl isomerase 8 (FKBP8) (Bhujabal et al, 2017), prohibitin 2 (PHB2) (Wei et al, 2017), and NLR family member X1 (NLRX1) (Zhang et al, 2019); lipid-mediated mitophagy receptors, including ceramide (Sentelle et al, 2012) and cardiolipin (Li et al, 2015).…”
Section: Overview Of the Mitophagymentioning
confidence: 99%
“…To our knowledge, the most studied and understood mitophagy pathway is mediated by PTEN-induced kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin (Narendra et al, 2008;Vives-Bauza et al, 2010), both of which have been linked to forms of Parkinson's disease (Kitada et al, 1998;Valente et al, 2004). The complicated mechanisms of canonical and non-canonical PINK1/parkinmediated mitophagy have been well summarized in previous reviews (Eiyama and Okamoto, 2015;Lazarou et al, 2015;Nguyen et al, 2016;Clark et al, 2020;Malpartida et al, 2020). Moreover, two main types of receptor-mediated mitophagy pathway have been classified as follows in brief: ubiquitinindependent mitophagy receptors, including BCL2-interacting protein 3 (BNIP3) (Quinsay et al, 2010), BCL2-interacting protein 3 like (NIX/BNIP3L) (Sandoval et al, 2008), FUN14 domain-containing 1 (FUNDC1) (Liu et al, 2012), BCL2-like 13 (BCL2L13) (Otsu et al, 2015), autophagy and beclin 1 regulator 1 (AMBRA1) (Strappazzon et al, 2015), FKBP prolyl isomerase 8 (FKBP8) (Bhujabal et al, 2017), prohibitin 2 (PHB2) (Wei et al, 2017), and NLR family member X1 (NLRX1) (Zhang et al, 2019); lipid-mediated mitophagy receptors, including ceramide (Sentelle et al, 2012) and cardiolipin (Li et al, 2015).…”
Section: Overview Of the Mitophagymentioning
confidence: 99%
“…As the name of Parkin, this protein is widely known as the protein associated with PD. Neurodegeneration in PD is related to mitochondrial dysfunction, and recently, studies have shown that PINK1/Parkin-dependent mitophagy responding to mitochondrial damage is associated with PD (Malpartida et al, 2021). Besides, there has been a study on the pathogenesis of PD through the association between α-synuclein aggregation and neuroinflammation (Liu et al, 2019).…”
Section: Clinical Roles Of the Autophagic Organelles In Ddrs Molecular Pathology Of Ddr-related Autophagic Organellesmentioning
confidence: 99%
“…Systemic administration of the dopamine precursor L-3,4-dihydroxyphenylalanine (L-dopa) is the gold standard for PD treatment, and, over time, almost all PD patients require this pharmacological treatment [ 4 ]. Several pathophysiological mechanisms have been suggested to underlie the neurodegeneration of PD, including mitochondrial impairment, which seems to be an early event in PD [ 5 ].…”
Section: Introductionmentioning
confidence: 99%